SGMT

Sagimet Biosciences Inc.

• Benzinga·2d ago

  Sagimet to Share Mid-Stage Liver Disease Drug Data at Medical Conference

• Reuters·2d ago

  Sagimet grants 9,600 inducement stock options to new hire under Nasdaq rule exception

• Reuters·2d ago

  SAGIMET BIOSCIENCES ANNOUNCES POSTER AND ORAL PRESENTATIONS AT THE FUELING MASH: METABOLIC DRIVERS AND INFLAMMATORY CROSSTALK KEYSTONE SYMPOSIUM AND INDUCEMENT GRANT UNDER NASDAQ LISTING RULE 5635(C)(4)

• TipRanks·6d ago

  Barclays Sticks to Their Hold Rating for Sagimet Biosciences, Inc. Class A (SGMT)

• TipRanks·03/31 20:00

  Analysts Offer Insights on Healthcare Companies: BioNano Genomics (BNGO) and Sagimet Biosciences, Inc. Class A (SGMT)

• TipRanks·03/26 11:46

  Sagimet Biosciences initiated with a Buy at Rodman & Renshaw

• TipRanks·03/20 11:36

  Guggenheim Keeps Their Buy Rating on Sagimet Biosciences, Inc. Class A (SGMT)

• TipRanks·03/13 09:50

  Analysts Offer Insights on Healthcare Companies: Korro Bio (KRRO), Sagimet Biosciences, Inc. Class A (SGMT) and Bristol-Myers Squibb (BMY)

• TipRanks·03/12 18:05

  Sagimet: Advancing FASN Inhibitor Pipeline and Solid Cash Position Support Buy Rating and $26 Target

• TipRanks·03/12 17:10

  Analysts Offer Insights on Healthcare Companies: Tenaya Therapeutics (TNYA) and Sagimet Biosciences, Inc. Class A (SGMT)

• TipRanks·03/12 15:25

  Sagimet: Underappreciated, De-Risked Pipeline with Near-Term Milestones Supports Buy Rating

• TipRanks·03/12 12:20

  Analysts’ Top Healthcare Picks: BridgeBio Pharma (BBIO), Tenet Healthcare (THC)

• Seeking Alpha·03/11 19:35

  Sagimet Biosciences GAAP EPS of -$0.29

• TipRanks·03/11 18:30

  Wall Street Analysts Are Bullish on Top Healthcare Picks

• Dow Jones·03/11 17:38

  Sagimet Biosciences Price Target Maintained With a $29.00/Share by HC Wainwright & Co.